Find uplifting stories about heroes, innovations, and solutions
7944 results for "melanoma treatment"
Federal regulators just approved a groundbreaking melanoma treatment that transforms the herpes virus into a cancer-fighting weapon. For patients whose advanced skin cancer stopped responding to standard treatments, this innovative therapy offers new hope.
University of Texas researchers solved a decade-long puzzle about why melanoma treatments work better when gradually reduced rather than stopped and restarted. Their discovery could help over 112,000 Americans diagnosed with melanoma this year get more effective care with fewer side effects.
A promising viral cancer therapy just cleared a major hurdle, giving new hope to advanced melanoma patients. After two rejections, an FDA expert panel voted 10-3 to recommend Replimune's innovative treatment for review.
A groundbreaking new therapy turns advanced melanoma patients' own tumors into powerful weapons against cancer. Dana-Farber and Mass General Hospital are now offering this personalized treatment to patients who need it most.
A New Orleans patient became the first in Louisiana to receive a breakthrough melanoma treatment that saves their eye, eliminating the need for removal or distant travel. The procedure offers new hope for eye cancer patients across the Gulf Coast.
A groundbreaking cancer therapy now lets doctors turn advanced melanoma tumors into personalized healing machines. The FDA-approved TIL therapy harnesses immune cells from a patient's own tumor to fight back against the disease.
Scientists at a Wisconsin VA hospital have discovered how to slow aggressive melanoma growth by targeting a specific protein, offering new hope for veterans facing one of the military's most common service-connected cancers.
A personalized mRNA cancer vaccine has shown remarkable success in preventing melanoma from returning and spreading in late-stage trials. Thousands of high-risk melanoma patients could benefit as soon as next year if regulators approve the groundbreaking treatment.
Scientists created a heat-activated patch that killed 97% of melanoma lesions in mice without damaging healthy skin. The experimental treatment could one day replace invasive surgery for early-stage skin cancer.
After years of setbacks, a new treatment for advanced melanoma just won FDA approval, giving patients a powerful option when other therapies have failed. The drug could help thousands facing one of the deadliest forms of skin cancer.
A breakthrough therapy is giving advanced melanoma patients new hope by supercharging their own immune systems to fight cancer. One survivor has remained cancer-free for six years after treatment.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
Jenney was diagnosed with stage 4 metastatic melanoma, a cancer that once meant almost certain death. Thanks to immunotherapy, she had no evidence of disease after just five months of treatment.
Scientists turned cancer's silent escape into an immune system alarm using tiny carriers that force tumors to die loudly. In mice, the treatment reprogrammed melanoma to train the body to fight back.
A personalized mRNA vaccine combined with immunotherapy slashed skin cancer recurrence rates in over 1,000 high-risk melanoma patients. It's the first late-stage trial success for mRNA cancer treatment, opening new hope for patients worldwide.
A personalized mRNA cancer vaccine combined with existing treatment stopped melanoma from returning in a major clinical trial. The breakthrough could open a powerful new way to fight cancer using the same technology that powered COVID vaccines.
A personalized mRNA cancer vaccine combined with existing treatment successfully slowed melanoma's return in a groundbreaking late-stage trial. This first-of-its-kind success could open new doors for cancer patients worldwide.
)
A simple daily capsule is helping melanoma patients who stopped responding to cancer treatment, offering new hope where options ran out. The gut-friendly therapy passed its first major safety test across four countries.
Researchers in Finland discovered how to potentially break the inflammatory cycle that helps aggressive skin cancer spread. The breakthrough could lead to new treatments that stop melanoma cells from communicating with immune cells that accidentally help tumors grow.
A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.
Showing 20 of 7944